Arrowstreet Capital’s Veracyte VCYT Stock Holding History

Arrowstreet Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.57M	Buy	+141,811	New	+$5.25M	﹤0.01%	1188
2025 Q3	–	Sell	-325,524	Closed	-$8.8M	–	2124
2025 Q2	$8.8M	Sell	325,524 -165,322	-34%	-$4.79M	0.01%	942
2025 Q1	$14.6M	Sell	490,846 -144,264	-23%	-$5.5M	0.01%	696
2024 Q4	$25.2M	Buy	635,110 +363,862	+134%	+$13.8M	0.02%	532
2024 Q3	$9.23M	Buy	+271,248	New	+$7.63M	0.01%	774
2020 Q1	–	Sell	-12,000	Closed	-$335K	–	2134
2019 Q4	$335K	Buy	+12,000	New	+$311K	﹤0.01%	1555

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Arrowstreet Capital's VCYT Position: Q1 2026 in Review

Arrowstreet Capital opened a new position in Veracyte (VCYT) in Q1 2026: 141,811 shares worth $4.57M. The stake represents ﹤0.01% of the portfolio and ranks #1188 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in VCYT as recently as Q2 2025.

Arrowstreet Capital first reported a position in VCYT in Q4 2019 and has held it in 6 quarters since. The position peaked at $25.2M in Q4 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Arrowstreet Capital held 141,811 shares of Veracyte worth $4.57M as of Q1 2026.
Veracyte was a new Arrowstreet Capital position in Q1 2026.
Veracyte made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1188 holding.
Arrowstreet Capital first reported a position in Veracyte in Q4 2019 and has held it in 6 quarters since.
Arrowstreet Capital's Veracyte position peaked at $25.2M in Q4 2024.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.